IRON
Price
$44.52
Change
+$0.23 (+0.52%)
Updated
May 9, 02:39 PM (EDT)
Capitalization
1.53B
91 days until earnings call
URGN
Price
$10.67
Change
+$0.55 (+5.43%)
Updated
May 8 closing price
Capitalization
466.61M
3 days until earnings call
Ad is loading...

IRON vs URGN

Header iconIRON vs URGN Comparison
Open Charts IRON vs URGNBanner chart's image
Disc Medicine
Price$44.52
Change+$0.23 (+0.52%)
Volume$489
Capitalization1.53B
UroGen Pharma
Price$10.67
Change+$0.55 (+5.43%)
Volume$603.18K
Capitalization466.61M
IRON vs URGN Comparison Chart
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. URGN commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Hold and URGN is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (IRON: $44.29 vs. URGN: $10.67)
Brand notoriety: IRON and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 112% vs. URGN: 110%
Market capitalization -- IRON: $1.53B vs. URGN: $466.61M
IRON [@Biotechnology] is valued at $1.53B. URGN’s [@Biotechnology] market capitalization is $466.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 3 TA indicator(s) are bullish while URGN’s TA Score has 5 bullish TA indicator(s).

  • IRON’s TA Score: 3 bullish, 6 bearish.
  • URGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, URGN is a better buy in the short-term than IRON.

Price Growth

IRON (@Biotechnology) experienced а -10.85% price change this week, while URGN (@Biotechnology) price change was -6.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was -13.36%.

Reported Earning Dates

IRON is expected to report earnings on Aug 08, 2025.

URGN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($1.53B) has a higher market cap than URGN($467M). URGN YTD gains are higher at: 0.188 vs. IRON (-30.142). IRON (-108.27M) and URGN (-110.34M) have comparable annual earnings (EBITDA) . IRON has more cash in the bank: 490M vs. URGN (237M). IRON has less debt than URGN: IRON (30M) vs URGN (123M). URGN has higher revenues than IRON: URGN (90.4M) vs IRON (0).
IRONURGNIRON / URGN
Capitalization1.53B467M328%
EBITDA-108.27M-110.34M98%
Gain YTD-30.1420.188-16,050%
P/E RatioN/AN/A-
Revenue090.4M-
Total Cash490M237M207%
Total Debt30M123M24%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONURGN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SOPVX46.43N/A
N/A
Allspring Opportunity A
NEMRX20.71N/A
N/A
Neuberger Berman Emerg Mkts Eq R3
NLSAX18.84N/A
N/A
Neuberger Berman Long Short A
BCSCX8.37N/A
N/A
BlackRock Commodity Strategies Inv C
FSEQX12.19N/A
N/A
Fidelity Advisor Sustainable U.S. Eq I

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with KMSTF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+1.70%
KMSTF - IRON
54%
Loosely correlated
N/A
ATBPF - IRON
53%
Loosely correlated
N/A
ATXS - IRON
46%
Loosely correlated
-0.45%
ERAS - IRON
44%
Loosely correlated
+13.47%
IDYA - IRON
44%
Loosely correlated
+1.96%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with IRON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+5.43%
IRON - URGN
40%
Loosely correlated
+1.70%
IDYA - URGN
39%
Loosely correlated
+1.96%
OCUL - URGN
39%
Loosely correlated
+5.67%
CGON - URGN
39%
Loosely correlated
+8.01%
CYYNF - URGN
38%
Loosely correlated
N/A
More